Pfizer Inc Analyst and Investor Call to Review Oncology Business Transcript
Good day, everyone, and welcome to Pfizer's analyst and investor call to review Oncology business. Today's call is being recorded.
At this time, I would like to turn the call over to Mr. Chuck Triano, Senior Vice President of Investor Relations. Please go ahead, sir.
Thank you, operator. Good morning, and good afternoon, everyone. And thanks for joining us today to provide an update on our oncology pipeline progress, specifically how we are applying our capabilities to move more quickly and utilize cutting-edge science to key programs.
As a note, we plan to conduct a series of these sessions across our therapeutic areas as our pipeline progresses, and we have new data and insights to share with you all.
We'll be making forward-looking statements during this call and actual results may be different. Additional information regarding forward-looking statements is available in our SEC filings on our forms 10-K and 10-Q.
Forward-looking statements on this call speak only as of the
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
